The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125761011 12576101 1 I 201508 20160711 20160720 20160720 EXP US-SA-2016SA128925 AVENTIS 87.00 YR E F Y 69.80000 KG 20160720 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125761011 12576101 1 PS LANTUS INSULIN GLARGINE 1 Unknown U NK 21081
125761011 12576101 2 SS LANTUS INSULIN GLARGINE 1 Unknown U UNK 21081 1X
125761011 12576101 3 SS JAKAFI RUXOLITINIB 1 Oral AD6457F 0 15 MG TABLET QD
125761011 12576101 4 SS JAKAFI RUXOLITINIB 1 Oral AD6457F 0 15 MG TABLET QD
125761011 12576101 5 SS JAKAFI RUXOLITINIB 1 Oral UNK 0 15 MG TABLET QD
125761011 12576101 6 SS JAKAFI RUXOLITINIB 1 Oral UNK 0 15 MG TABLET QD
125761011 12576101 7 SS NOVOLOG INSULIN ASPART 1 Unknown U UNK 0
125761011 12576101 8 C FERROUS SULFATE. FERROUS SULFATE 1 0
125761011 12576101 9 C ATENOLOL. ATENOLOL 1 0
125761011 12576101 10 C BALSALAZIDE BALSALAZIDE 1 0
125761011 12576101 11 C CALCIUM CALCIUM 1 0
125761011 12576101 12 C VITAMIN D CHOLECALCIFEROL 1 0
125761011 12576101 13 C FISH OIL FISH OIL 1 0
125761011 12576101 14 C LASIX FUROSEMIDE 1 0
125761011 12576101 15 C WARFARIN WARFARIN 1 0
125761011 12576101 16 C CEFUROXIME. CEFUROXIME 1 0
125761011 12576101 17 C SPIRONOLACTONE. SPIRONOLACTONE 1 0
125761011 12576101 18 C OMEPRAZOLE. OMEPRAZOLE 1 0
125761011 12576101 19 C SIMVASTATIN. SIMVASTATIN 1 0
125761011 12576101 20 C LEVOTHYROXINE. LEVOTHYROXINE 1 0
125761011 12576101 21 C ASPIRIN. ASPIRIN 1 0
125761011 12576101 22 C ASACOL MESALAMINE 1 0
125761011 12576101 23 C COUMADIN WARFARIN SODIUM 1 0
125761011 12576101 24 C GAS-X DIMETHICONE 1 0
125761011 12576101 25 C LISINOPRIL. LISINOPRIL 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125761011 12576101 3 Myelofibrosis
125761011 12576101 4 Myelofibrosis
125761011 12576101 5 Myelofibrosis
125761011 12576101 6 Myelofibrosis

Outcome of event

Event ID CASEID OUTC COD
125761011 12576101 OT
125761011 12576101 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125761011 12576101 Anaemia
125761011 12576101 Contusion
125761011 12576101 Pneumonia
125761011 12576101 Pulmonary thrombosis
125761011 12576101 Shock hypoglycaemic
125761011 12576101 Splenomegaly
125761011 12576101 Thrombosis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125761011 12576101 3 20120723 0
125761011 12576101 4 20120723 0